PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71964-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)71964-7/fulltext
Title : PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71964-7&doi=10.1016/S1098-3015(11)71964-7
First page : A264
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 126
Categories :
Tags :
Regions :
ViH Article Tags :